Oppenheimer Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-69,083
| Closed | -$6.32M | – | 1129 |
|
|
2023
Q2 | $6.32M | Sell |
69,083
-1,195
| -2% | -$109K | 0.09% | 248 |
|
|
2023
Q1 | $5.17M | Buy |
70,278
+4,730
| +7% | +$348K | 0.08% | 273 |
|
|
2022
Q4 | $5.48M | Sell |
65,548
-7,278
| -10% | -$608K | 0.09% | 242 |
|
|
2022
Q3 | $7.05M | Sell |
72,826
-2,343
| -3% | -$227K | 0.12% | 209 |
|
|
2022
Q2 | $7.9M | Sell |
75,169
-3,430
| -4% | -$361K | 0.13% | 186 |
|
|
2022
Q1 | $13.5M | Buy |
78,599
+3,030
| +4% | +$522K | 0.19% | 129 |
|
|
2021
Q4 | $12.2M | Buy |
75,569
+24,038
| +47% | +$3.89M | 0.16% | 152 |
|
|
2021
Q3 | $7.68M | Buy |
51,531
+469
| +0.9% | +$69.9K | 0.11% | 218 |
|
|
2021
Q2 | $12.5M | Buy |
51,062
+5,906
| +13% | +$1.45M | 0.18% | 131 |
|
|
2021
Q1 | $12M | Buy |
45,156
+6,085
| +16% | +$1.61M | 0.19% | 132 |
|
|
2020
Q4 | $11.5M | Buy |
39,071
+639
| +2% | +$187K | 0.19% | 129 |
|
|
2020
Q3 | $9.09M | Buy |
38,432
+1,293
| +3% | +$306K | 0.18% | 148 |
|
|
2020
Q2 | $7.37M | Buy |
37,139
+2,540
| +7% | +$504K | 0.15% | 163 |
|
|
2020
Q1 | $6.35M | Buy |
34,599
+413
| +1% | +$75.8K | 0.16% | 157 |
|
|
2019
Q4 | $5.71M | Buy |
34,186
+416
| +1% | +$69.4K | 0.12% | 203 |
|
|
2019
Q3 | $4.42M | Sell |
33,770
-599
| -2% | -$78.5K | 0.1% | 243 |
|
|
2019
Q2 | $4.17M | Buy |
+34,369
| New | +$4.17M | 0.09% | 257 |
|